ArticleInternational journal of molecular sciences2024

Ripasudil as a Potential Therapeutic Agent in Treating Secondary Glaucoma in HTLV-1-Uveitis: An In Vitro Analysis.

Mingming Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.